(0)
The Supervisory Board of Synthon BV, an international, science-centered pharmaceutical company specialized in developing and manufacturing high-quality generic and hybrid medicines for patients around the world, is pleased to announce that Anish Mehta is appointed as Chief Executive Officer and member of the Board of Directors, effective immediately. We are delighted to welcome Anish to Synthon , said Hans Stols, Executive Chairman. Anish s successful track record, deep industry expertise and his energetic and result-driven personality will help Synthon to continue delivering on our purpose of developing therapies that improve health and well-being globally.
Anish is a global healthcare veteran with more than 20 years of experience in innovative and generic pharmaceuticals. Prior to joining Synthon, Anish was the Chief Executive Officer of Theramex, a global specialty pharma company dedicated to Women s Health, where he established the company following the acquisition an